-
2
-
-
0024417601
-
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer
-
Slevin ML, Clark PI, Joel SP, et al: A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. J Clin Oncol 7:1333-1340, 1989
-
(1989)
J Clin Oncol
, vol.7
, pp. 1333-1340
-
-
Slevin, M.L.1
Clark, P.I.2
Joel, S.P.3
-
3
-
-
0001184894
-
A pharmacokinetic hypothesis for the clinical efficacy of etoposide in small cell lung cancer
-
abstr
-
Clark PI, Joel SP, Slevin ML: A pharmacokinetic hypothesis for the clinical efficacy of etoposide in small cell lung cancer. Proc Am Soc Clin Oncol 8:66, 1989 (abstr)
-
(1989)
Proc Am Soc Clin Oncol
, vol.8
, pp. 66
-
-
Clark, P.I.1
Joel, S.P.2
Slevin, M.L.3
-
4
-
-
0024505316
-
Chronic daily administration of oral etoposide - A phase I trial
-
Hainsworth JD, Johnson DH, Frazier SR, et al: Chronic daily administration of oral etoposide - A phase I trial. J Clin Oncol 7:396-401, 1989
-
(1989)
J Clin Oncol
, vol.7
, pp. 396-401
-
-
Hainsworth, J.D.1
Johnson, D.H.2
Frazier, S.R.3
-
5
-
-
0025130651
-
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: A phase II trial
-
Johnson DH, Greco FA, Strupp J: Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: A phase II trial. J Clin Oncol 8:1613-1617, 1940
-
(1940)
J Clin Oncol
, vol.8
, pp. 1613-1617
-
-
Johnson, D.H.1
Greco, F.A.2
Strupp, J.3
-
6
-
-
0025162020
-
Phase II trial of daily oral VP-16 in refractory small cell lung cancer: A Hoosier Oncology Group study
-
Einhorn LW, Pennington K, McClean J: Phase II trial of daily oral VP-16 in refractory small cell lung cancer: A Hoosier Oncology Group study. Semin Oncol 17:32-35, 1990
-
(1990)
Semin Oncol
, vol.17
, pp. 32-35
-
-
Einhorn, L.W.1
Pennington, K.2
McClean, J.3
-
7
-
-
0024371468
-
A phase II study of oral etoposide in elderly patients with small cell lung cancer
-
Smit EF, Carney DN, Harford P, et al: A phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax 44:631-633, 1989
-
(1989)
Thorax
, vol.44
, pp. 631-633
-
-
Smit, E.F.1
Carney, D.N.2
Harford, P.3
-
8
-
-
0001690080
-
Prolonged administration of single-agent oral etoposide in patients with untreated small cell lung cancer
-
abstr
-
Clark PI, Cottier B, Joel SP, et al: Prolonged administration of single-agent oral etoposide in patients with untreated small cell lung cancer. Proc Am Soc Clin Oncol 9:226, 1990 (abstr)
-
(1990)
Proc Am Soc Clin Oncol
, vol.9
, pp. 226
-
-
Clark, P.I.1
Cottier, B.2
Joel, S.P.3
-
9
-
-
0025141586
-
Phase II study of daily oral etoposide in refractory germ cell tumors
-
Miller JC, Einhorn LH: Phase II study of daily oral etoposide in refractory germ cell tumors. Semin Oncol 17:36-39, 1990
-
(1990)
Semin Oncol
, vol.17
, pp. 36-39
-
-
Miller, J.C.1
Einhorn, L.H.2
-
10
-
-
0025145356
-
Chronic daily administration of oral etoposide in refractory lymphoma
-
Hainsworth JD, Johnson DH, Frazier SR, et al: Chronic daily administration of oral etoposide in refractory lymphoma. Eur J Cancer 26:818-821, 1990
-
(1990)
Eur J Cancer
, vol.26
, pp. 818-821
-
-
Hainsworth, J.D.1
Johnson, D.H.2
Frazier, S.R.3
-
11
-
-
2642713777
-
Phase II trial of daily oral etoposide in patients with surgically unresectable non-small cell lung cancer
-
abstr
-
Saxman S, Logie K, Stephens D, et al: Phase II trial of daily oral etoposide in patients with surgically unresectable non-small cell lung cancer. Proc Am Soc Clin Oncol 9:238, 1990 (abstr)
-
(1990)
Proc Am Soc Clin Oncol
, vol.9
, pp. 238
-
-
Saxman, S.1
Logie, K.2
Stephens, D.3
-
12
-
-
0026547005
-
Prolonged administration of oral etoposide in non-small cell lung cancer: A phase II trial
-
Waits TM, Johnson DH, Hainsworth JD, et al: Prolonged administration of oral etoposide in non-small cell lung cancer: A phase II trial. J Clin Oncol 10:292-296, 1992
-
(1992)
J Clin Oncol
, vol.10
, pp. 292-296
-
-
Waits, T.M.1
Johnson, D.H.2
Hainsworth, J.D.3
-
13
-
-
84910968324
-
Cisplatin (P) & prolonged administration of oral etoposide (E) in extensive small cell lung cancer (ESCLC) patients (PT): A phase II trial
-
abstr
-
Murphy PB, Hainsworth JD, Greco FA, et al: Cisplatin (P) & prolonged administration of oral etoposide (E) in extensive small cell lung cancer (ESCLC) patients (PT): A phase II trial. Proc Am Soc Clin Oncol 10:257, 1991 (abstr)
-
(1991)
Proc Am Soc Clin Oncol
, vol.10
, pp. 257
-
-
Murphy, P.B.1
Hainsworth, J.D.2
Greco, F.A.3
-
14
-
-
84910968324
-
Carboplatin (CBDCA) plus prolonged administration of oral etoposide (E) in the treatment of non-small cell lung cancer (NSCLC): A phase I/II trial
-
abstr
-
Walls J, Devore R, Hainsworth JD, et al: Carboplatin (CBDCA) plus prolonged administration of oral etoposide (E) in the treatment of non-small cell lung cancer (NSCLC): A phase I/II trial. Proc Am Soc Clin Oncol 10:257, 1991 (abstr)
-
(1991)
Proc Am Soc Clin Oncol
, vol.10
, pp. 257
-
-
Walls, J.1
Devore, R.2
Hainsworth, J.D.3
-
16
-
-
0024412440
-
The effect of dose on the bioavailability of oral etoposide: Confirmation of a clinically relevant observation
-
Slevin ML, Joel SP, Whomsley R, et al: The effect of dose on the bioavailability of oral etoposide: Confirmation of a clinically relevant observation. Cancer Chemother Pharmacol 24:329-331, 1989
-
(1989)
Cancer Chemother Pharmacol
, vol.24
, pp. 329-331
-
-
Slevin, M.L.1
Joel, S.P.2
Whomsley, R.3
-
17
-
-
1542302306
-
Improved bioavailability (BA) with low dose oral (PO) etoposide (E)
-
abstr
-
Hande KR, Bennett RB, Krozley MG, et al: Improved bioavailability (BA) with low dose oral (PO) etoposide (E). Proc Am Soc Clin Oncol 10:96, 1991 (abstr)
-
(1991)
Proc Am Soc Clin Oncol
, vol.10
, pp. 96
-
-
Hande, K.R.1
Bennett, R.B.2
Krozley, M.G.3
-
18
-
-
0001349582
-
The bioavailability of oral etoposide during prolonged administration and development of a limited sampling strategy for the estimation of AUC after an oral dose
-
abstr
-
Joel SP, Dolega-Ossowksi E, Jones K, et al: The bioavailability of oral etoposide during prolonged administration and development of a limited sampling strategy for the estimation of AUC after an oral dose. Proc Am Assoc Cancer Res 32:178, 1991 (abstr)
-
(1991)
Proc Am Assoc Cancer Res
, vol.32
, pp. 178
-
-
Joel, S.P.1
Dolega-Ossowksi, E.2
Jones, K.3
-
19
-
-
0022414303
-
The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide
-
Harvey VJ, Slevin ME, Joel SP, et al: The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide. Br J Cancer 52:363-367, 1985
-
(1985)
Br J Cancer
, vol.52
, pp. 363-367
-
-
Harvey, V.J.1
Slevin, M.E.2
Joel, S.P.3
-
21
-
-
0002374550
-
Single classification analysis of variance
-
New York, NY, Freeman
-
Sokal RR, Rohlf FJ: Single classification analysis of variance, in Biometry: The Principles and Practice of Statistics in Biological Research (ed 2). New York, NY, Freeman, 1981, pp 208-270
-
Biometry: The Principles and Practice of Statistics in Biological Research (Ed 2)
, vol.1981
, pp. 208-270
-
-
Sokal, R.R.1
Rohlf, F.J.2
-
22
-
-
0019785890
-
Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models
-
Holford NHG, Sheiner LB: Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 6:429-453, 1981
-
(1981)
Clin Pharmacokinet
, vol.6
, pp. 429-453
-
-
Holford, N.H.G.1
Sheiner, L.B.2
-
23
-
-
85034935564
-
-
New York, NY, Wiley
-
Draper NR, Smith H: Applied Regression Analysis (ed 2). New York, NY, Wiley, 1981, pp 141-192
-
Applied Regression Analysis (Ed 2)
, vol.1981
, pp. 141-192
-
-
Draper, N.R.1
Smith, H.2
-
25
-
-
0025080582
-
Low-dose oral etoposide: A new role for an old drug?
-
editorial
-
Slevin ML: Low-dose oral etoposide: A new role for an old drug? J Clin Oncol 8:1607-1609, 1990 (editorial)
-
(1990)
J Clin Oncol
, vol.8
, pp. 1607-1609
-
-
Slevin, M.L.1
-
27
-
-
0025194085
-
Is chemotherapy for metastatic non small cell lung cancer 'worth if?
-
editorial
-
Ruckdeschel JC: Is chemotherapy for metastatic non small cell lung cancer 'worth if? J Clin Oncol 8:1293-1295, 1990 (editorial)
-
(1990)
J Clin Oncol
, vol.8
, pp. 1293-1295
-
-
Ruckdeschel, J.C.1
-
28
-
-
0025744506
-
Pharmacologically based dosing of etoposide: A means of safely increasing dose intensity
-
Ratain MJ, Mick R, Schilsky RL, et al: Pharmacologically based dosing of etoposide: A means of safely increasing dose intensity. J Clin Oncol 9:1480-1486, 1991
-
(1991)
J Clin Oncol
, vol.9
, pp. 1480-1486
-
-
Ratain, M.J.1
Mick, R.2
Schilsky, R.L.3
-
30
-
-
0026004507
-
Modeling interpatient pharmacodynamic variability of etoposide
-
Mick R, Ratain MJ: Modeling interpatient pharmacodynamic variability of etoposide. J Natl Cancer Inst 83:1560-1564, 1991
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 1560-1564
-
-
Mick, R.1
Ratain, M.J.2
-
31
-
-
0026079516
-
Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole
-
Trump DL, Egorin MJ, Forrest A, et al: Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole. J Clin Oncol 9:2027-2035, 1991
-
(1991)
J Clin Oncol
, vol.9
, pp. 2027-2035
-
-
Trump, D.L.1
Egorin, M.J.2
Forrest, A.3
-
32
-
-
0023031031
-
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy
-
O'Connel JP, Kris MG, Grall RJ, et al: Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol 4:1604-1614, 1986
-
(1986)
J Clin Oncol
, vol.4
, pp. 1604-1614
-
-
O'Connel, J.P.1
Kris, M.G.2
Grall, R.J.3
|